The most commonly used method to quantify Ki-67 expression is immunohistochemistry (IHC), which is not practical for the dynamic monitoring of Ki-67 during lung cancer treatment because of invasion, which is time-consuming (12). The gene discussed is MKI67; the disease is lung carcinoma.